David Domzalski, CEO at Foamix Pharmaceuticals Ltd. (FOMX), sold 67 shares at $5.26 ($352) on 2018-06-01, disclosed to the SEC on 2018-06-04.
Open-market sale of $352 FOMX by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FOMX | SELL | 2019-04-03 | $19K | — | Filing → |
| FOMX | SELL | 2018-12-06 | $275 | — | Filing → |
| FOMX | SELL | 2018-11-20 | $20K | — | Filing → |